Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Oral Rehabil ; 2024 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-38475861

RESUMEN

OBJECTIVE: The objective of this commentary is to advocate for a holistic, ontology-based definition of bruxism. The intention is to synthesise the best aspects of current definitions into a structured ontological model, thereby refining and enhancing a comprehensive understanding of the full spectrum of bruxism. MATERIALS AND METHODS: The commentary elaborates on the process of integrating these insights into a hierarchical ontology that aligns with ontological principles. SETTINGS AND SAMPLE POPULATION: Not directly applicable as this is a commentary. RESULTS/CONCLUSION: The proposed ontology-based definition of bruxism aims to clarify communication within the medical community and advance research by enabling a comprehensive ontology-based classification of bruxism. By aligning with ontological principles, this approach aspires to act as a catalyst for further research, discussion and consensus in the field.

2.
Toxins (Basel) ; 14(10)2022 09 30.
Artículo en Inglés | MEDLINE | ID: mdl-36287949

RESUMEN

BACKGROUND: Tardive Oromandibular Dystonia is an iatrogenic drug-induced movement form of extrapyramidal symptoms associated primarily with chronic consumption of dopamine receptor blocking agents. Tardive symptoms attributable to selective serotonin reuptake inhibitors antidepressants are far less prevalent. CLINICAL CASE: The authors will present a clinical case and management, from the dental specialist perspective, of a 55-year-old female patient who developed tardive oromandibular dystonia induced by Trazodone prescribed for sleep insomnia. CONCLUSIONS: Trazodone-induced oromandibular dystonia is extremely rare. Early identification and assessment of tardive symptoms are imperative for successful treatment. Trazodone should be prescribed with caution in patients taking other medications with the potential to cause tardive syndromes.


Asunto(s)
Distonía , Trastornos Distónicos , Trazodona , Femenino , Humanos , Persona de Mediana Edad , Distonía/inducido químicamente , Distonía/diagnóstico , Distonía/tratamiento farmacológico , Trazodona/efectos adversos , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico , Receptores Dopaminérgicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...